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Abstract
Objective: Liver disease is an important cause of morbidity and mortality globally. Its pattern varies in different 
geographical locations. This study aimed to determine the pattern and risk factors of liver disease in a Nigerian tertiary 
hospital.
Study Design: Retrospective
Study Site: University of Nigeria teaching hospital Ituku/Ozalla, Enugu state, Nigeria.
Materials and Methods: Case notes of patients admitted with a diagnosis of liver disease were reviewed and information 
relating to demographics, risk factors for liver disease and results of relevant investigations extracted.
Results: Liver diseases accounted for 7.9% of medical admissions, with primary liver cancer and liver cirrhosis accounting 
for 44.3% and 20.4%, respectively. The main risk factors were alcohol consumption (52.1%), hepatitis B virus infection 
(49.4%), ingestion of herbs and roots (45.5%) and cigarette smoking (30.1%).
Conclusion: Liver cirrhosis and primary liver cancer account for two thirds of liver disease in hospitalized patients in 
a Nigerian tertiary hospital. The major putative risk factors are alcohol consumption, hepatitis B virus infection, use of 
herbs and roots and smoking.
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Introduction
The liver is a vital organ that plays a major role in human 
metabolism. Because of its peculiar anatomy and physiology, 
it is extremely susceptible to the influence of a wide variety 
of injurious agents including infections and toxins. Liver 
damage may also result from immunologic and ischaemic 
processes that characterize various systemic disorders.
Liver disease has a worldwide distribution.[1] Very often; 
affected individuals are asymptomatic for a long period of 
time, making it very difficult to generate accurate incidence 
and prevalence data in the general population. The pattern 
of liver disease varies in different geographical locations. 
In the United States, cirrhosis is the twelfth leading cause 
of hospitalization and death.[2] The prevalence of major 
causes of chronic liver disease (CLD) remained stable in the 
United States between 1988 and 2008, except non‑alcoholic 
fatty liver disease (NAFLD), which increased steadily and 
is expected to continue to contribute substantially to the 
burden of CLD because of increasing rates of obesity.[3]
Viral hepatitis remains a leading cause of morbidity and 
mortality affecting millions of individuals worldwide. 
According to the World Health Organization (WHO), 2 
billion people have been infected with the hepatitis B virus 
(HBV), and more than 350 million have chronic HBV 
infection.[4] In addition, it has been estimated that up to 3% 
of the world’s population have been infected with hepatitis 
C virus (HCV) of which 170 million people are chronically 
infected.[5]
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Hepatocellular carcinoma (HCC) is a major cause of death 
by cancer worldwide, accounting for over half a million 
deaths per year.[6,7] In men, HCC is the fifth most frequently 
diagnosed cancer worldwide, and is also the second leading 
cause of cancer‑related death in the world.[8]
In most of Africa, and indeed Nigeria, there is paucity 
of reliable statistics regarding liver‑related morbidity and 
mortality. Knowledge of the pattern of liver disease is useful, 
not only in formulating health policies and prioritizing 
health interventions and research, but may also aid in 
planning the structure and activities of gastroenterology 
units for provision of better and effective patient care.
The main objective of this study was to determine the 
relative frequencies of liver diseases and their putative 
aetiological factors in patients admitted to the medical wards 
of the University of Nigeria Teaching Hospital (UNTH) 
Ituku/Ozalla, Enugu State of Nigeria.
Materials and Methods
This was a retrospective analysis of patients admitted to the 
medical wards of the University of Nigeria Teaching Hospital 
Ituku/Ozalla, Enugu State of Nigeria from January 1, 2005 to 
December 31, 2010. Case notes of patients with a diagnosis 
of liver disease during the period under review were retrieved 
and relevant information extracted from them, including 
demographic data, results of laboratory tests and final diagnosis. 
Liver disease was diagnosed with typical clinical features, 
abdominal ultrasonography, computerized tomography scans, 
biochemical tests of liver function, serological tests for viral 
hepatitis, coagulation studies, liver biopsy and viral molecular 
tests in varying combinations depending on the clinical context.
On the basis of the final diagnosis, the following categories 
of liver disease were identified: Acute hepatitis, chronic 
hepatitis, liver cirrhosis, primary liver cancer (PLC), 
secondary liver cancer, liver abscess and unclassified 
group. Similarly, based on results of relevant investigations, 
aetiological factors identified were hepatitis B virus (HBV), 
hepatitis C virus (HCV), alcohol, smoking and cryptogenic.
The results were expressed as means and proportions for 
continuous and discrete variables, respectively.
Results
Of the 8,211 patients admitted to the medical wards 
during the 6‑year period, 652 (7.9%) had various forms 
of liver disease. They consisted of 443 males (67.9%) and 
209 females (32.1%). The mean age of the patients with liver 
disease was 46.4 ± 18.0 years. The commonest liver diseases 
were PLC (44.3%) and liver cirrhosis (20.4%). Unclassified 
liver disease accounted for 12.7% of the cases [Table 1].
Putative aetiological and risk factors [Table 2] were evidence 
of previous hepatitis B virus (HBV) infection (49.4%), 
evidence of previous hepatitis C virus (HCV) infection 
(8.4%), alcohol consumption (52.1%), cigarette smoking 
(30.1%) use of native herbs and roots (45.5%), and family 
history of liver disease (10.6%).
Hepatitis B surface antigen (HBsAg) in blood was present in 
61.4% of patients with PLC and 45.9% of patients with liver 
cirrhosis. Anti‑HCV was present in 10.9% of patients with 
primary liver cancer and 5.4% of patients with liver cirrhosis.
Discussion
Liver diseases accounted for 7.9% of adult medical 
admissions during the study period. This proportion is 
comparable to the results obtained from other centers across 
Nigeria[9‑11] although those studies dealt with causes of death 
rather than reasons for hospitalization. The total number of 
medical admissions during the period seems low for a tertiary 
hospital with about 600 beds. One major reason for the 
observation is that the hospital relocated to its permanent 
site during the study period and that significantly affected 
patient attendance for some time.
Table 2: Risk factors for liver disease




Hepatitis B surface antigen 
seropositivity (n=257)
127 49.4
Use of herbs and roots 
(n=365)
166 45.5
Cigarette smoking (n=512) 154 30.1






Table 1: Pattern of liver disease in hospitalized 
patients
Liver disease Number of patients Percentage
Primary liver cancer 289 44.3
Liver cirrhosis 133 20.4
Acute hepatitis 41 6.3
Metastatic liver disease 32 4.9
Liver abscess 25 3.8
Obstructive jaundice 22 3.4
Chronic hepatitis 14 2.1
Hepatic encephalopathy 5 0.8
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Liver cancer and liver cirrhosis accounted for nearly two 
thirds of liver‑related admissions while acute hepatitis and 
chronic hepatitis accounted for very few. The reasons for 
this are not far fetched. In a hospital‑based study such as 
this, it is expected that only the severe forms of a disease, 
often in its terminal stages are seen in the tertiary centers. 
Furthermore, evidence for hepatitis B virus infection is 
found in about 60% of chronic liver disease in Nigeria.[12‑15] 
The epidemiologic pattern of HBV infection in most high 
prevalence areas like Nigeria is that infection occurs very 
early in life. Such infections are usually anicteric with 
attendant high risk of chronicity. Even the chronic phase 
of the disease is often asymptomatic. Most patients get to 
know about their HBV status when they come down with 
decompensated liver cirrhosis or PLC. There is a large pool 
of asymptomatic HBV infection in the community that can 
only be detected by mass screening.
The patients whose liver disease could not be classified 
are a very important group. The reasons for not classifying 
them include very late presentation with little or no time to 
conclude investigations before death and lack of adequate 
laboratory support to make the correct diagnosis.
This study also highlighted the leading role of HBV in the 
causation of liver disease in Nigeria. This finding has been 
reported by previous researchers on this subject.[12‑15]
It is noteworthy that close to a third of patients with liver 
disease gave a history of cigarette smoking. Though the 
quantity smoked could not be ascertained because of the 
retrospective nature of the study, the finding suggests that 
there may be an association between cigarette smoking 
and liver disease. Smoking yields toxins, which induce 
inflammation and increase the severity of hepatic fibrosis 
and activity scores when associated with HCV[16] or HBV.[17] 
Cigarette smoking increases the risk of developing HCC 
among CLD patients.[18] Association of smoking with HCC 
irrespective of HBV status has been reported.[19,20] A meta‑
analysis of epidemiologic studies on cigarette smoking and 
liver cancer showed that tobacco smoking is associated with 
liver cancer development[21]; a finding with an important 
public health message for areas with high liver cancer 
incidence. A case‑control study carried out in Ibadan, 
South‑West Nigeria about 22 years ago showed that the 
relative risk of cigarette smoking in HCC was not found to 
be statistically significant.[22] Disease transition consequent 
upon changing lifestyles may account for the disparate 
results. This calls for well‑designed studies to determine the 
current magnitude of this risk factor in a place like Nigeria 
where liver disease burden is substantial.
History of alcohol consumption was obtained from over 
half of the liver disease patients. Though there is no data 
on the quantity consumed and duration of consumption, 
other factors that may accelerate alcohol‑induced liver 
damage include pattern of drinking, gender, coexisting 
viral hepatitis infection, genetic factors, iron overload and 
diet.[23] Since most of these factors are rife in Nigeria, it is 
very likely that alcohol acts in concert with other factors to 
produce liver disease even when the level of consumption 
does not exceed the generally accepted safe limit.[24] A study 
from South‑West Nigeria showed that liver cancer has a 
stronger association with alcohol consumption than other 
chronic liver diseases.[25]
Hepatitis C virus infection was a risk factor for liver cancer in 
10.9% of patients. This is comparable to the results obtained 
in earlier studies from Lagos, South West Nigeria[26] and 
Ilorin, North Central Nigeria.[27,28] where the seroprevalence 
was 12.2% and 14.4%, respectively. The contribution of 
HCV to liver disease in Nigeria is significantly less than 
that of HBV. This is the reverse of the situation in Western 
Europe and North America where HCV is a leading cause 
of chronic liver disease.[29]
This study also highlighted a possible association between 
consumption of herbs/roots and liver disease. Complementary 
and alternative therapies including herbal products have 
become increasingly popular in the general population 
and among patients and physicians. Patients perceive 
these products as natural and therefore safe. However, the 
literature is replete with reports of hepatotoxicity.[30‑32] In 
some instances; these herbs are prepared in very unhygienic 
conditions using alcohol, among other additives, thereby 
exposing the consumers to multiple hepatotoxins. 
Regulations regarding herbs are still incomplete, and need 
to be improved.
Family history of liver disease was obtained from 10.6% of 
patients with liver disease. Hepatitis B virus is a leading 
cause of liver disease.[12‑15] Familial clustering of HBV 
infection has been described in many studies.[33,34] In 
endemic regions of the world such as South‑East Asia and 
Africa, vertical transmission from mother to newborn and 
horizontal transmission among children play an important 
role in intra‑familial transmission of HBV. Hepatitis B virus 
infection was found in a study to be the likely reason for the 
familial aggregation of liver cancer in Southern China.[35]
The limitations of this study include its retrospective design, 
lack of adequate investigative capacity for liver diseases, 
diagnostic nihilism on the part of attending physicians 
and poor record keeping. Management of viral hepatitis 
in resource‑ poor countries like Nigeria is currently facing 
enormous challenges, which border on lack of proper 
knowledge of the disease by the populace, as well as health 
care workers, paucity of skilled personnel, lack of laboratory 
support, especially molecular diagnostic techniques and 
emerging issues of co‑infection with other viruses.[36] 
Another limitation is the fact that the hospital record system 
is yet to be computerized. Some case notes could not be 
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located and even when the case notes were available; some 
of the results of investigations were missing.
In conclusion, liver disease is an important cause of 
morbidity in Nigerians. Cirrhosis and primary liver cancer 
account for two‑thirds of liver disease‑related admissions 
in our hospital. The major putative risk factors are hepatitis 
B virus infection, alcohol consumption, use of herbs and 
roots, cigarette smoking, family history of liver disease and 
hepatitis C virus infection.
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